source
- Novartis pulls Pluvicto prostate cancer label expansion filing in the EUNovartis has withdrawn its EU application for Pluvicto's expansion into earlier prostate cancer treatment, despite US and UK approval for the same indication. The Swiss drugmaker failed to gain fav…Endpoints · 3mo ago↗ source
- Exclusive: UC Berkeley startup bets on jumping genes for GLP-1 gene therapyThe new generation of weight loss medicines does an unprecedented job of keeping off the pounds — if people stay on the drugs. Yet numerous studies suggest most of those who start taking GLP-1 drug…Endpoints · 3mo ago↗ source
- International childhood vaccine campaign growsIn today's Morning Rounds newsletter, a new era in GOP drug policy, an international childhood vaccine campaign grows, and more.